Dersimelagon prolongs the amount of time patients with erythropoietic protoporphyria can spend outside without experiencing symptoms: NEJM.

Published Date: 21 Apr 2023

USA: Dersimelagon at a dose of 100 or 300 mg once daily for 16 weeks significantly increased the amount of time patients with could spend outside without experiencing any symptoms.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nuclear missile workers are contracting cancer: They blame the bases

2.

Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants

3.

New analysis helps discern benign from malignant thyroid growths

4.

MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information

5.

Even a few mutated cells can significantly impact how blood cancers develop, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot